All.Can Patient Survey

72 Italy About this survey in Italy The survey in Italy was conducted in partnership with All.Can Italy. Data collection took place from 27 September – 30 November 2018. A total of 96 people took part in the Italian survey. Respondent profile • Cancer type: breast 25% ; urological 25% ; skin 22% ; other (various cancer types, all <5%) 29% • Gender: female 66% ; male 34% • Age: 0–24 2% ; 25–64 79% ; 65+ 17% ; not specified 1% Where did inefficiencies occur most? • Dealing with the psychological impacts: 25% • My initial cancer diagnosis: 24% • Dealing with ongoing side effects: 11% • Access to patient support groups: 11% i AIOM. 2018. I numeri del cancro in Italia. Available online at https://www.fondazioneaiom.it/wp-content/uploads/2018/10/2018_ NumeriCancro-pazienti.pdf ’Cancer is a disease that must be addressed with a 360-degree view, and psychological support is necessary for the patient or for their partner.’ Cancer represents the second leading cause of death in Italy. In 2018, there were 3.3 million people living with and beyond cancer, and an incidence of 373,000 new cases that year. i